Walleye Trading
CSII

Walleye Trading’s Cardiovascular Systems, Inc. CSII Stock Holding History

Walleye Trading’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,594
Closed -$31.7K – 5478
2023
Q1 		$31.7K Buy
+1,594
New +$27.5K ﹤0.01% 4171
2022
Q4 		– Sell
-14,056
Closed -$195K – 5590
2022
Q3 		$195K Buy
+14,056
New +$209K ﹤0.01% 3694
2022
Q1 		– Sell
-21,202
Closed -$398K – 6117
2021
Q4 		$398K Buy
+21,202
New +$566K ﹤0.01% 3179
2020
Q2 		– Sell
-6,276
Closed -$221K – 4743
2020
Q1 		$221K Buy
6,276
+4,400
+235% +$185K ﹤0.01% 2525
2019
Q4 		$91K Buy
1,876
+676
+56% +$30.8K ﹤0.01% 3600
2019
Q3 		$57K Buy
+1,200
New +$56.4K ﹤0.01% 3530
2017
Q2 		– Sell
-2,600
Closed -$74K – 5088
2017
Q1 		$74K Buy
2,600
+2,500
+2,500% +$66.4K ﹤0.01% 3582
2016
Q4 		$2K Sell
100
-1,900
-95% -$46.6K ﹤0.01% 4576
2016
Q3 		$47K Buy
+2,000
New +$43.8K ﹤0.01% 3798

Other funds holding CSII

UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Huntington National Bank
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Walleye Trading's CSII Position: Q2 2023 in Review

Walleye Trading sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 1,594 shares — an estimated $31.7K sold.

Walleye Trading first reported a position in CSII in Q3 2016 and held it in 9 quarters. The position peaked at $398K in Q4 2021. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Walleye Trading reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 1,594 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $31.7K.
  • Walleye Trading first reported a position in Cardiovascular Systems, Inc. in Q3 2016 and held it in 9 quarters.
  • Walleye Trading's Cardiovascular Systems, Inc. position peaked at $398K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.